Approval · Notice of Compliance 12085 · 2011
ORGALUTRAN: Notice of Compliance 12085
Issued February 16, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12085
- Date
- February 16, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Gonadotropin-releasing hormone (GnRH) antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGALUTRAN | 02245641 | Marketed |
Medicinal ingredients
- GANIRELIX ACETATE 250 MCG per 0.5ML